Table 3.
Prevalence of co-morbidities, associated mortality, incidence of septic shock, and ICU admission per co-morbidity
| Type of co-morbidity a | Number of patients (%) | 28 day mortality (%) | Septic shock (%) | Admitted to the ICU (%) |
|---|---|---|---|---|
| Cardiovascular disease |
136 (27%) |
25 (18%) |
18 (13%) |
26 (19%) |
| Lung disease |
125 (24%) |
20 (16%) |
20 (16%) |
26 (21%) |
| Neurological disease |
67 (13%) |
12 (18%) |
9 (13%) |
10 (15%) |
| Diabetes mellitus |
61 (12%) |
10 (6%) |
12 (20%) |
12 (20%) |
| Solid cancer |
50 (10%) |
7 (14%) |
5 (10%) |
5 (10%) |
| Hematologic diseaseb |
48 (10%) |
9 (19%) |
4 (8%) |
5 (10%) |
| Immunosuppressionc | 55 (11%) | 11 (20%) | 8 (14%) | 11 (20%) |
aOther reported co-morbidities were in descending order; renal disease (n=23), autoimmune disease (n=19), liver disease (n=17), splenectomy (n=4) and HIV (n=3).
bHematologic disease includes hematological malignancies.
cPharmacological immunosuppression was noted if the patient was treated with biological drugs, methotrexate or corticosteroids equivalent to ≥ 10 mg prednisolone.